Heska (HSKA) Interest Expense : $-3.8 Mil (TTM As of Mar. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Heska Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Heska's interest expense for the three months ended in Mar. 2023 was $ -0.9 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2023 was $-3.8 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Heska's Operating Income for the three months ended in Mar. 2023 was $ -10.4 Mil. Heska's Interest Expense for the three months ended in Mar. 2023 was $ -0.9 Mil. Heska did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Heska Interest Expense Historical Data

The historical data trend for Heska's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heska Interest Expense Chart

Heska Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-0.31

-3.09

-6.37

-4.20

-4.19

Heska Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Interest Expense	Get a 7-Day Free Trial															-0.93	-0.48	-1.17	-1.16	-0.94

Heska Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.8 Mil.

Heska (NAS:HSKA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Heska's Interest Expense for the three months ended in Mar. 2023 was $-0.9 Mil. Its Operating Income for the three months ended in Mar. 2023 was $-10.4 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2023 was $105.4 Mil.

Heska's Interest Coverage for the quarter that ended in Mar. 2023 is calculated as

Heska did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Heska (HSKA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heska Corp (NAS:HSKA) » Definitions » Interest Expense

Comparable Companies

AHCO SILK AVNS UFPT FNA PRCT SIBN CTKB OM TMCI ABT MDT SYK BSX EW SZSE:300760 DXCM ZBH ALGN STE

Traded in Other Exchanges

N/A

Address

3760 Rocky Mountain Avenue, Loveland, CO, USA, 80538

Website

https://www.heska.com

Heska Corp is engaged in developing, manufacturing, marketing, selling, and supporting veterinary products. The company's products include Point of Care diagnostic laboratory instruments and consumables; Point of Care digital imaging diagnostic products; reference laboratory testing; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; single-use offerings such as in-clinic diagnostic tests and heartworm preventive products; and practice information management software and related software. It operates through two segments North America and International. The Company's core strategic focus on Point of Care laboratory and imaging products is included in both segments.

Executives

Joachim A. Hasenmaier	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Robert L Antin	director
Mark F Furlong	director	770 M WATER ST, MILWAUKEE WI 53202
Stephen L Davis	director	2901 BUTTERFIELD ROAD, OAK BROOK IL 60523
Providenti Anthony C. Jr.	officer: EVP, Corporate Development	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Kevin S. Wilson	officer: President and COO	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Eleanor F. Baker	officer: EVP, Managing Dir. & COO, scil	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Christopher D. Sveen	officer: CAO & General Counsel	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Nancy Wisnewski	officer: EVP, Prod. Dev. & Cust. Supp	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Sharon L. Riley	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Catherine Grassman	officer: EVP, CFO	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Jason D Aroesty	officer: EVP, International Diagnostics	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Bonnie J. Trowbridge	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Scott Humphrey	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Jason A Napolitano	officer: Exec. VP, CFO & Secretary	1613 PROSPECT PARKWAY, FORT COLLINS CO 80525